Fourth Quarter Highlights:
Full Year 2021 Highlights:
ATLANTA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the fourth quarter and full year 2021. Alimera will host a conference call on February 24, 2022, at 9:00 a.m. ET to discuss these results and provide an update on corporate developments.
Read more at globenewswire.com